Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine, artesunate, mefloquine-artesunate and tribendimidine against opisthorchiasis
ISRCTN23425032Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Mar 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of mefloquine, artesunate, praziquantel and tribendimidine in opisthorchiasis (5 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoints: Cure rate and Egg reduction rate. Started Mar 2010; status: completed.
02
Drugs
mefloquineartesunatepraziquanteltribendimidine
03
Conditions
opisthorchiasis
Beyond the preview
Go deeper on ISRCTN23425032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN23425032.